Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 568 followers
Latest posts
Last updated 4 days ago
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
5 days ago
Voluntary agreement delivers on all four of President Trump’s requests and reduces...
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
8 days ago
SWIFT data included reduction in exacerbations requiring hospitalisation and/or emergency department visits...
Exdensur (depemokimab) approved in the UK for treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
8 days ago
Approval based on data from the SWIFT and ANCHOR phase III trials.
Nucala (mepolizumab) receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease (COPD)
12 days ago
Nucala is the only monthly biologic studied in a wide COPD population...
Depemokimab receives positive CHMP opinion for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
12 days ago
If approved, depemokimab will be the first and only ultra-long-acting biologic in...
GSK’s RSV vaccine, Arexvy, receives positive CHMP opinion for all adults 18 years and older
12 days ago
Marketing authorisation expected in February 2026
Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urogenital gonorrhoea (uGC)
13 days ago
Blujepa is the first in a new antibiotic class for the treatment...
GSK’227, a B7-H3-targeted antibody-drug conjugate, granted Orphan Drug Designation in small-cell lung cancer by the US FDA
14 days ago
Designation supported by early clinical data showing durable responses in certain types...
GSK data at ASH show potential to redefine outcomes for people living with blood cancers
23 days ago
GSK will present new data from its haematology portfolio at the 67th...
TESARO, a GSK subsidiary, initiates litigation against AnaptysBio, Inc.
about 1 month ago
TESARO, Inc., confirms it has initiated litigation against AnaptysBio, Inc. in the...
GSK and LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology
about 1 month ago
Supports GSK's focus of using novel technologies in areas of disease expertise...
GSK and Fleming Initiative scientists unite to target AMR with advanced AI
about 1 month ago
£45m GSK funding allocated to 6 new research programmes combining expertise and...